Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade

Medical device specialist DexCom (DXCM -0.90%) has substantially underperformed the market over the trailing-12-month period. The diabetes-focused company disappointed investors last year due to unimpressive financial results, especially in the second and third quarters.However, despite its recent woes, DexCom still looks like an excellent long-term option for growth-oriented investors. In fact, the company could beat the market in the next decade. Read on to find out why.Riding the CGM waveDexCom develops ...